- Coronavirus outbreak: The countries affected
- Coronavirus: Countries with suspected cases
- GSK’s Zejula meets primary goal in Phase III ovarian cancer trial
- Trials data suggests Cosentyx from Novartis will change psoriasis market
- Myeloma UK launches research programme to support myeloma clinical trials
OnAsset Intelligence Accomplishes Significant Breakthrough In The Development Of NexBox
As countries around the world continue to adapt their lives to the Covid-19 pandemic, the utilisation of online and direct to consumer deliveries is increasing dramatically.
Funding secured for UK clinical trial in children with neuroblastoma
A team from the University of Birmingham will organise the UK arm of a critical European clinical trial for children diagnosed with a rare and aggressive childhood cancer called neuroblastoma.
Defeating the Spread of Covid-19 with Laboratory Equipment from IKA
IKA recommends a number of its renowned products from its extensive portfolio for preparatory DNA / RNA purification and extraction.
ACTide Against Covid-19 from Nubilaria
Major announcement for Researchers and Health Professionals in Europe who wish to commit to the fight against Covid-19: a powerful acceleration of research to gain understanding and facts is required.
Retevmo (selpercatinib) for the Treatment of RET-Driven Cancers
Retevmo™ (selpercatinib) is the first therapy approved for the treatment of three rearranged during transfection (RET)-driven cancer indications.